Stay updated with breaking news from Report Series. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Corporater, a global leader in software solutions for Integrated Governance, Performance, Risk, and Compliance (GPRC) Management, is proud to...
– Results from pivotal Phase 2b ReNeu trialofmirdametinib in patients with NF1-PN to be presented in an oral presentation –
– Results from Phase 2b ReNeu trial of mirdametinib in NF1-PN accepted for oral presentation –
(This story has not been edited by THE WEEK and is auto-generated from a PTI
The Central Drugs Standard Control Organisation (CDSCO) has released draft guidelines on good distribution practices to prevent the introduction of spurious, adulterated, and sub-standard pharmaceutical products in the market. The guidelines are in line with the WHO Technical Report Series on good storage and distribution practices for such products.